The Costs and Outcomes of Tuberculosis Treatment at Primary Health Care Clinics in an Urban Township, South Africa
The actual implementation of DOTS across South Africa varies widely. Implementation of DOTS may differ between the intensive phase of treatment (first 2-3 months, with daily injections for the retreatment regimen and a 4-drug fixed combination pill for both first-line regimens) and the continuation phase of treatment (consisting of a daily, 2-drug fixed combination pill). In either phase, the treatment supervisor may be a nurse or counselor at a healthcare facility, a lay healthworker from the community, a relative, the patient’s employer, an NGO caregiver, another caregiver, a volunteer, or someone else. The alternative to any one of these supervisors is unsupervised treatment in which the patient is solely responsible, without a supervisor. The objective of this retrospective record review is to determine the cost of treatment for drug-sensitive TB at two public sector primary health care clinics in Johannesburg, South Africa, stratified by treatment outcome and by model of DOTS implementation.
The following publications emanate from this project:
Outcomes of TB/HIV co- infected patients presenting with antituberculosis drug-induced liver injury
TB treatment outcomes by type of treatment supervision in Johannesburg, South Africa
HE2RO staff involvedProfessor Sydney Rosen Constance Mongwenyana Dr. Kate Shearer
Stay up to date
Receive newsletters and keep up to date with developments at HE2RO.